$OKLO

Narayanadas Vivek sold $23K of OKLO

Narayanadas Vivek (General Counsel & Secretary) sold 649 shares of Oklo Inc. (OKLO) at $35.93 on 2026-10-05.

Original reporting
SEC EDGAR · Narayanadas Vivek
Published Oct 6, 2026, 8:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OKLO
Bearish
medium confidence
Mentioned
$OKLO
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLOBearishLow
01

Why it matters

The transaction is small and unlikely to move the stock materially, but it adds to the flow of insider activity data.

02

Market read

A routine insider sale with limited market impact; useful for tracking insider trends but not a trading catalyst.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed in the filing.

Relevance 3/10Novelty 3/10Timing: today

Background

SEC Form 4 filing discloses an insider transaction by Oklo Inc.'s General Counsel.

Company-level read

Ticker impact

$OKLOBearishMedium confidence
Context

General Counsel Narayanadas Vivek sold 649 shares for $23,318.57 on 2026-10-05

Expected impact

likely modest selling pressure as the market prices the insider divestiture

Evidence & confidence

The sale represents less than 1% of the insider's post‑transaction holdings and is under $30k, limiting market impact.

Market effects

Minimal effect on the nuclear energy sector; insider activity is routine.

No discernible regional impact.

Insignificant on a global scale.

Counterpoint

The sale could be unrelated to company fundamentals and merely personal liquidity needs.

Key entities

  • Oklo Inc.

    U.S.-listed nuclear fuel developer (ticker OKLO).

  • Narayanadas Vivek

    General Counsel & Secretary of Oklo, reporting an insider sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SMRLowAI 8/10

NuScale Power Falls 7% as 10-Year Treasury Yield Climbs to 5.26%; Energy Fuels Drops 9%, Oklo Slides 5%

NuScale Power (SMR) fell 7% to $6.04, Energy Fuels (UUUU) dropped 9% to $8.43, and Oklo (OKLO) slid 5% to $30.11 as 10-year Treasury yields rose to 5.26%. The Global X Uranium ETF (URA) declined 4%, outpacing the broader market's 0.8% drop. Rising yields impact long-duration assets like nuclear developers, affecting both valuation and project financing costs.

$OKLOHigh

Oklo Launched Another $1 Billion Stock Sale. Here's How Much Dilution Shareholders Have Absorbed Since It Went Public.

Oklo (NYSE: OKLO), a nuclear energy company, launched a $1 billion stock sale on Sept. 11, adding to prior sales since its May 2024 SPAC merger. Outstanding shares increased 58% to 192.3 million, diluting early shareholders by 37%. Despite a 311% share price increase, Oklo's stock hit a 52-week low on Oct. 8, requiring more shares to raise the same capital.

$GOOGHighAI 8/10

Google Signed a Deal for Existing Reactors. So Why Did Oklo and NuScale Jump on the Constellation Energy News? The Read-Through Investors Are Missing.

Alphabet (GOOG, GOOGL) agreed to a 15-year and 20-year deal with Constellation Energy (CEG) for nuclear power, investing $4.3B in new capacity. Oklo (OKLO) and NuScale (SMR) shares also rose, despite no direct involvement. The companies develop small modular reactors (SMRs) for specific facilities, differing from Constellation's large-scale plants. Investors see broader nuclear energy growth, with SMRs expected to play a significant role by 2050, according to industry estimates.

$OKLOMed

Oklo (OKLO) Dropped, So What Is Driving Attention Now?

Oklo, a modular nuclear reactor company, focuses on selling long-term electricity contracts. It secured NRC approval for its Aurora design, has $1.6B cash, and partnerships with NVDA, META, and Switch. However, it reports $33M net loss, no revenue, and no operating plants. Market cap is $11B. Regulatory hurdles remain.

$OKLOMed

Oklo selected for DOE isotope production initiative

Oklo Inc. (NYSE:OKLO) was chosen by the U.S. Department of Energy to advance its Groves 2 Forge facility, focusing on producing lutetium-177 for cancer treatments. The project is part of the DOE’s initiative to boost domestic nuclear reactor development and isotope production. Oklo aims to transition from pilot to commercial-scale operations with regulatory approvals.